Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells

European Journal of Pharmacology

Volumn 636, Issue 1-3, 2010, Pages 114-120

  Wu, Xing ^a,b   Lin, Daowei ^a,b   Li, Guofu ^a,c   Zuo, Zhiyi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cells; Postconditioning; Protein kinase B; Statin

Indexed keywords

ATORVASTATIN; GUANOSINE TRIPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIMVASTATIN; SUPEROXIDE;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CELL DAMAGE; COMPLEX FORMATION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PULMONARY ARTERY; REPERFUSION; SIMULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIA; OXYGEN; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY ARTERY;

EID: 77952674048     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.028     Document Type: Article

References (26)

1. Anger T., El-Chafchak J., Habib A., Stumpf C., Weyand M., Daniel W.G., Hombach V., Hoeher M., Garlichs C.D. Statins stimulate RGS-regulated ERK 1/2 activation in human calcified and stenotic aortic valves. Exp. Mol. Pathol. 2008, 85:101-111.
2. Chen W., Pendyala S., Natarajan V., Garcia J.G., Jacobson J.R. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L575-L583.
3. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004, 109. III39-43.
4. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
5. Domoki F., Kis B., Gaspar T., Snipes J.A., Parks J.S., Bari F., Busija D.W. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell Physiol. 2009, 296:C97-C105.
6. Gu W., Kehl F., Krolikowski J.G., Pagel P.S., Warltier D.C., Kersten J.R. Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. Anesthesiology 2008, 108:634-642.
7. Gwag B.J., Won S.J., Kim D.Y. Excitotoxicity, oxidative stress, and apoptosis in ischemic neuronal death. New Concepts in Cerebral Ischemia 2001, 79-112. CRC Press, New York. C.S. Lin (Ed.).
8. Hermann M., Asberg A., Christensen H., Holdaas H., Hartmann A., Reubsaet J.L. Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients. Clin. Pharmacol. Ther. 2004, 76:388-391.
9. Hordijk P.L. Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 2006, 98:453-462.
10. Kim J.A., Li L., Zuo Z. Isoflurane induces a postconditioning effect on bovine pulmonary arterial endothelial cells exposed to oxygen-glucose deprivation. Eur. J. Pharmacol. 2009, 615:144-149.
11. Kruger P.S., Freir N.M., Venkatesh B., Robertson T.A., Roberts M.S., Jones M. A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med. 2009, 35:717-721.
12. Lazar H.L., Bao Y., Zhang Y., Bernard S.A. Pretreatment with statins enhances myocardial protection during coronary revascularization. J. Thorac. Cardiovasc. Surg. 2003, 125:1037-1042.
13. Lee J.J., Li L., Jung H.-H., Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008, 108:1055-1062.
14. Merla R., Daher I.N., Ye Y., Uretsky B.F., Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am. Heart J. 2007, 154:391-402.
15. Merla R., Ye Y., Lin Y., Manickavasagam S., Huang M.H., Perez-Polo R.J., Uretsky B.F., Birnbaum Y. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1918-H1928.
16. Miida T., Hirayama S., Nakamura Y. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. J. Atheroscler. Thromb. 2004, 11:253-264.
17. Nakata S., Tsutsui M., Shimokawa H., Yamashita T., Tanimoto A., Tasaki H., Ozumi K., Sabanai K., Morishita T., Suda O., Hirano H., Sasaguri Y., Nakashima Y., Yanagihara N. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. Arterioscler. Thromb. Vasc. Biol. 2007, 27:92-98.
18. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
19. Prinz V., Laufs U., Gertz K., Kronenberg G., Balkaya M., Leithner C., Lindauer U., Endres M. Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke 2008, 39:433-438.
20. Raphael J., Abedat S., Rivo J., Meir K., Beeri R., Pugatsch T., Zuo Z., Gozal Y. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via akt signaling and modulation of Bcl-2 family proteins. J. Pharmacol. Exp. Ther. 2006, 318:186-194.
21. Rikitake Y., Liao J.K. Rho GTPases, statins, and nitric oxide. Circ. Res. 2005, 97:1232-1235.
22. Sugiura S., Yagita Y., Sasaki T., Todo K., Terasaki Y., Ohyama N., Hori M., Kitagawa K. Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion. Brain Res. 2007, 1181:125-129.
23. Weihrauch D., Krolikowski J.G., Bienengraeber M., Kersten J.R., Warltier D.C., Pagel P.S. Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth. Analg. 2005, 101:942-949.
24. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H579-H588.
25. Zuo Z., Johns R.A. Inhalational anesthetics up-regulate constitutive and lipopolysaccharide-induced inducible nitric oxide synthase expression and activity. Mol. Pharmacol. 1997, 52:606-612.
26. Zuo Z., Wang Y., Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur. J. Pharmacol. 2006, 542:84-91.